Acarix AB (publ) ACARIX

Updated: 10 Aug 2026

NASDAQ | Biotech | Medical technology / diagnostics

No signal published yet

We already track Acarix and collect the news. No signal is published yet — follow the company free and we will email you when that changes, or run a quick check now.

Follow Acarix free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Free
No email, no account, no signup.
Exchange
NASDAQ
Type
Biotech
Sector
Medical technology / diagnostics
We're already tracking Acarix AB (publ) — here are the latest events we've registered

Recent News

  • On August 10, 2026, Acarix announced that its CADScor System received regulatory approval in the United Arab Emirates. The clearance enables commercial availability of the technology across the UAE in partnership with local distributor UniTech Solutions.

What Firelda Watch includes for Acarix AB (publ)

Add the company to your watchlist and get all of this automatically.

  • Free: 3 companies on your watchlist
  • Change history and monitoring for every company you follow
  • Sunday weekly brief — a short weekly roundup
  • Watch/Ultra: same-day email when something material happens
Want to see what a finished analysis looks like?
View a sample analysis
This is a real Firelda analysis. Your analysis of Acarix AB (publ) will be delivered in the same format.

Want to follow Acarix AB (publ)? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.

Follow Acarix free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Acarix AB (publ) ACARIX
Acarix — follow and we'll monitor it
Follow Acarix free Follow free
Firelda provides general information and analysis, not personal investment advice. Content does not consider your financial situation or goals. Investments can rise and fall in value. Always do your own research.